Retraction
MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo
Paper Information
Record ID:
57764
Journal:
Cancer Medicine
(
Wiley
)
Publication Date:
January 18, 2019
Retraction Date:
October 10, 2024
(1.1 year years ago)
Subjects:
Institution:
Department of Neurosurgery, BeijingTiantan Hospital, Capital MedicalUniversity, Beijing, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (4)
4
Total Citations0
Post-Retraction3
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
The impact of MCCK1, an inhibitor of IKBKE kinase, on acute B lymphocyte leukemia cells
Shuangshuang Wen, Peng Zhao, Siyu Chen et al. (6 authors)
Mathematical Biosciences & Engineering
Open Access
Published: Jan 2024
283 days before retraction
Advances in IKBKE as a potential target for cancer therapy
Min Yin, Xin Wang, Jie Lu
Cancer Medicine
Open Access
Published: Nov 2019
53 citations
53 citations
1791 days before retraction
MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial‐mesenchymal transition of glioblastoma cells in vitro and in vivo
Tie Liu, Anqi Li, Yulun Xu et al. (4 authors)
Cancer Medicine
Open Access
Published: Jan 2019
3 citations
3 citations
2092 days before retraction
Quick Stats
Total Citations:
5
Years Since Retraction:
1.1 year
Open Access:
Yes
Last Checked:
Jul 24, 2025